R&D Update: What's on the Horizon for the Panic Disorder Market?

Table of Contents

• Executive Summary
  • Strategic Considerations
  • Stakeholder Implications
• Introduction
• Overview of Panic Disorder
  • Disease Description
  • Diagnosis
  • Pathophysiology of Panic Disorder
    • Norepinephrine
    • Serotonin
    • Gamma-Aminobutyric Acid
    • Glutamate
    • Corticotropin-Releasing Factor
    • Substance P
  • Prevalence of Panic Disorder
• Current Therapies for Panic Disorder
  • Selective Serotonin Reuptake Inhibitors
  • Serotonin and Norepinephrine Reuptake Inhibitors
  • Benzodiazepines
• Emerging Therapies for Panic Disorder
  • Sepracor' s SEP-225441
  • Alexza Pharmaceuticals' AZ-002
• Panic Disorder Market: 2007 Statistics and Future Outlook

Tables

• 1. Characteristics of a Panic Attack
• 2. Risk Factors for Panic Disorder
• 3. Therapies Commonly Used to Treat Panic Disorder, 2008
• 4. Agents in Development to Treat Anxiety Disorders, 2008
• 5. Sales of Agents to Treat Panic Disorder, 2007

Figures

• 1. Structures of the Brain Implicated in Panic Disorder
• 2. Prevalent Cases of Panic Disorder in the Major Markets, 2007 and 2012
• 3. Market Share of Drug Classes Used to Treat Panic Disorder, 2007